Results 131 to 140 of about 87,967 (330)

New Prospective Phosphodiesterase Inhibitors: Phosphorylated Oxazole Derivatives in Treatment of Hypertension. [PDF]

open access: yesAdv Pharm Bull, 2023
Nizhenkovska IV   +5 more
europepmc   +1 more source

A heat‐stable inhibitor protein for bovine brain cyclic nucleotide phosphodiesterase from Escherichia coli [PDF]

open access: bronze, 1981
Yasushi Iwasa   +4 more
openalex   +1 more source

Genital Psoriasis: Shining Light on This Hidden Disease

open access: yesJEADV Clinical Practice, EarlyView.
Psoriasis occurring on skin of the genital and perigenital regions has specific diagnostic and treatment requirements due to the sensitivity and private nature of these areas. A multidisciplinary group of experts in the management of genital psoriasis, the Genital Psoriasis Wellness Consortium, convened to discuss the impact of genital psoriasis on ...
Jennifer Cather   +19 more
wiley   +1 more source

Efficacy of Apremilast in Refractory Genital Psoriasis: A Retrospective Case Series

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background Genital pustular psoriasis is a rare and often underdiagnosed condition that can severely affect physical comfort, quality of life and psychological well‐being. It can be particularly challenging to manage, often requiring systemic therapies due to its potential unresponsiveness to conventional topical treatment.
Jonathan Krygier   +2 more
wiley   +1 more source

Purin-6-One Derivatives as Phosphodiesterase-2 Inhibitors

open access: yesJournal of Chemistry, 2016
A series of purin-6-one derivatives were synthesized, and their in vitro inhibitory activity against phosphodiesterase-2 (PDE2) was evaluated by using a fluorescence polarization assay.
Wei Yuan   +3 more
doaj   +1 more source

Induction of dark-adaptive retinomotor movement (cell elongation) in teleost retinal cones by cyclic adenosine 3,5-monophosphate. [PDF]

open access: yes, 1982
In the teleost retina, the photoreceptors and retinal pigment epithelium (RPE) undergo extensive movements (called retinomotor movements) in response to changes in light conditions and to an endogenous circadian rhythm.
BURNSIDE, Beth   +3 more
core  

Evaluation of the Therapeutic Index of a Novel Phosphodiesterase 4B– Selective Inhibitor Over Phosphodiesterase 4D in Mice

open access: yesJournal of Pharmacological Sciences, 2013
Phosphodiesterase 4 (PDE4) inhibitors have been developed for the treatment of pulmonary inflammatory diseases, but their clinical use was dose-limited by mainly gastric adverse effects.
Osamu Suzuki   +12 more
doaj  

Home - About - Disclaimer - Privacy